Eduardo Rene Salas

This profile gathers the share dealings of Eduardo Rene Salas across 2 companies, led by Adma Biologics, Inc. and Intra-Cellular Therapies, Inc. The record holds 4 filings, for trades running from 23 June 2024 to 9 February 2026.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Most recently, on 11 February 2026, the filings show a share grant in Adma Biologics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.